116 related articles for article (PubMed ID: 37948999)
21. KDM7 Demethylases: Regulation, Function and Therapeutic Targeting.
Shao P; Liu Q; Qi HH
Adv Exp Med Biol; 2023; 1433():167-184. PubMed ID: 37751140
[TBL] [Abstract][Full Text] [Related]
22. The clinical significance and biological function of lncRNA SOCAR in serous ovarian carcinoma.
Guo Q; Wang L; Zhu L; Lu X; Song Y; Sun J; Wu Z; Shi J; Wang Z; Zhou X
Gene; 2019 Sep; 713():143969. PubMed ID: 31299360
[TBL] [Abstract][Full Text] [Related]
23. Histone Demethylase Gene PHF2 Is Mutated in Gastric and Colorectal Cancers.
Lee JH; Yoo NJ; Kim MS; Lee SH
Pathol Oncol Res; 2017 Jul; 23(3):471-476. PubMed ID: 27744626
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia-inducible factor-1α induces CX3CR1 expression and promotes the epithelial to mesenchymal transition (EMT) in ovarian cancer cells.
Singh SK; Mishra MK; Singh R
J Ovarian Res; 2019 May; 12(1):42. PubMed ID: 31077234
[TBL] [Abstract][Full Text] [Related]
25. AT-rich interactive domain 5B regulates androgen receptor transcription in human prostate cancer cells.
Yamakawa T; Waer C; Itakura K
Prostate; 2018 Dec; 78(16):1238-1247. PubMed ID: 30027545
[TBL] [Abstract][Full Text] [Related]
26. Reproductive hormone-induced, STAT3-mediated interleukin 6 action in normal and malignant human ovarian surface epithelial cells.
Syed V; Ulinski G; Mok SC; Ho SM
J Natl Cancer Inst; 2002 Apr; 94(8):617-29. PubMed ID: 11959895
[TBL] [Abstract][Full Text] [Related]
27. Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer.
Li HZ; Wang Y; Gao Y; Shao J; Zhao XL; Deng WM; Liu YX; Yang J; Yao Z
Mol Cancer Res; 2008 Jun; 6(6):917-28. PubMed ID: 18567796
[TBL] [Abstract][Full Text] [Related]
28. In Ovarian Cancer Multicellular Spheroids, Platelet Releasate Promotes Growth, Expansion of ALDH+ and CD133+ Cancer Stem Cells, and Protection against the Cytotoxic Effects of Cisplatin, Carboplatin and Paclitaxel.
Casagrande N; Borghese C; Agostini F; Durante C; Mazzucato M; Colombatti A; Aldinucci D
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809553
[TBL] [Abstract][Full Text] [Related]
29. Non-catalytic region of tyrosine kinase adaptor protein 2 (NCK2) pathways as factor promoting aggressiveness in ovarian cancer.
Fanelli M; Camperchioli A; Petrella L; Petrillo M; Baranello C; Baccaro P; Paolillo C; Capoluongo E; Scambia G
Int J Biol Markers; 2018 Jan; 33(1):124-131. PubMed ID: 29218693
[TBL] [Abstract][Full Text] [Related]
30. miRNA-301b-3p accelerates migration and invasion of high-grade ovarian serous tumor via targeting CPEB3/EGFR axis.
Liu F; Zhang G; Lv S; Wen X; Liu P
J Cell Biochem; 2019 Aug; 120(8):12618-12627. PubMed ID: 30834603
[TBL] [Abstract][Full Text] [Related]
31. In vitro analysis of ovarian cancer response to cisplatin, carboplatin, and paclitaxel identifies common pathways that are also associated with overall patient survival.
Bicaku E; Xiong Y; Marchion DC; Chon HS; Stickles XB; Chen N; Judson PL; Hakam A; Gonzalez-Bosquet J; Wenham RM; Apte SM; Fulp W; Cubitt CL; Chen DT; Lancaster JM
Br J Cancer; 2012 Jun; 106(12):1967-75. PubMed ID: 22596241
[TBL] [Abstract][Full Text] [Related]
32. Blood monocyte transcriptome and epigenome analyses reveal loci associated with human atherosclerosis.
Liu Y; Reynolds LM; Ding J; Hou L; Lohman K; Young T; Cui W; Huang Z; Grenier C; Wan M; Stunnenberg HG; Siscovick D; Hou L; Psaty BM; Rich SS; Rotter JI; Kaufman JD; Burke GL; Murphy S; Jacobs DR; Post W; Hoeschele I; Bell DA; Herrington D; Parks JS; Tracy RP; McCall CE; Stein JH
Nat Commun; 2017 Aug; 8(1):393. PubMed ID: 28855511
[TBL] [Abstract][Full Text] [Related]
33. Phosphorylation of PHF2 by AMPK releases the repressive H3K9me2 and inhibits cancer metastasis.
Dong Y; Hu H; Zhang X; Zhang Y; Sun X; Wang H; Kan W; Tan MJ; Shi H; Zang Y; Li J
Signal Transduct Target Ther; 2023 Mar; 8(1):95. PubMed ID: 36872368
[TBL] [Abstract][Full Text] [Related]
34.
Xu H; Zhao X; Bhojwani D; E S; Goodings C; Zhang H; Seibel NL; Yang W; Li C; Carroll WL; Evans WE; Yang JJ
Clin Cancer Res; 2020 Jan; 26(1):256-264. PubMed ID: 31573954
[TBL] [Abstract][Full Text] [Related]
35. Novel insights into histone modifiers in adipogenesis.
Okuno Y; Inoue K; Imai Y
Adipocyte; 2013 Oct; 2(4):285-8. PubMed ID: 24052908
[TBL] [Abstract][Full Text] [Related]
36. The expression and biological function of the PHF2 gene in breast cancer.
Zhang L; Hui TL; Wei YX; Cao ZM; Feng F; Ren GS; Li F
RSC Adv; 2018 Nov; 8(69):39520-39528. PubMed ID: 35558021
[TBL] [Abstract][Full Text] [Related]
37. Microphthalmia-Associated Transcription Factor-Dependent Melanoma Cell Adhesion Molecule Activation Promotes Peritoneal Metastasis of Ovarian Cancer.
Kitami K; Yoshihara M; Koya Y; Sugiyama M; Iyoshi S; Uno K; Mogi K; Tano S; Fujimoto H; Nawa A; Kikkawa F; Kajiyama H
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371469
[TBL] [Abstract][Full Text] [Related]
38. Structural basis for human PHF2 Jumonji domain interaction with metal ions.
Horton JR; Upadhyay AK; Hashimoto H; Zhang X; Cheng X
J Mol Biol; 2011 Feb; 406(1):1-8. PubMed ID: 21167174
[TBL] [Abstract][Full Text] [Related]
39. Plant homeodomain finger protein 2 promotes bone formation by demethylating and activating Runx2 for osteoblast differentiation.
Kim HJ; Park JW; Lee KH; Yoon H; Shin DH; Ju UI; Seok SH; Lim SH; Lee ZH; Kim HH; Chun YS
Cell Res; 2014 Oct; 24(10):1231-49. PubMed ID: 25257467
[TBL] [Abstract][Full Text] [Related]
40. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
